ERBB2 and breast cancer: A large number of studies have found that young breast cancer have a worse prognosis than older breast cancer, because young breast cancer contain a higher proportion of aggressive molecular subtypes, such as triple negative and HER-2 positive subtypes [5, 6, 8, 9].